332 related articles for article (PubMed ID: 11937780)
1. Effect of YM-44781, YM-44778 and YM-49598, novel tachykinin antagonists, in a drug-induced bladder contraction model.
Choppin A; Groke G; Bringas A; Stepan G; Dillon MP
Pharmacology; 2002 May; 65(2):96-102. PubMed ID: 11937780
[TBL] [Abstract][Full Text] [Related]
2. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
3. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
[TBL] [Abstract][Full Text] [Related]
4. Tachykinin NK2 receptors in the hamster urinary bladder: in vitro and in vivo characterization.
Tramontana M; Patacchini R; Lecci A; Giuliani S; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):293-300. PubMed ID: 9774215
[TBL] [Abstract][Full Text] [Related]
5. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
6. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
7. Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors.
Kerr KP; Thai B; Coupar IM
Br J Pharmacol; 2000 Dec; 131(7):1461-7. PubMed ID: 11090121
[TBL] [Abstract][Full Text] [Related]
8. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory and motor responses by tachykinins in the guinea-pig oesophageal sphincter.
Conte B; Parlani M; Lopez G; Cirillo R; Maggi CA; Manzini S
J Auton Pharmacol; 1998 Oct; 18(5):313-7. PubMed ID: 9831232
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
[TBL] [Abstract][Full Text] [Related]
11. Tachykinins increase [3H]acetylcholine release in mouse striatum through multiple receptor subtypes.
Preston Z; Lee K; Widdowson L; Richardson PJ; Pinnock RD
Neuroscience; 2000; 95(2):367-76. PubMed ID: 10658616
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin receptors mediating contraction of guinea pig lung strips.
Killingsworth CR; Shore SA
Regul Pept; 1995 May; 57(2):149-61. PubMed ID: 7544902
[TBL] [Abstract][Full Text] [Related]
13. Endomorphins interact with tachykinin receptors.
Kosson P; Bonney I; Carr DB; Lipkowski AW
Peptides; 2005 Sep; 26(9):1667-9. PubMed ID: 16112408
[TBL] [Abstract][Full Text] [Related]
14. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
15. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
Goso C; Astolfi M; Parlani M; Manzini S
Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
[TBL] [Abstract][Full Text] [Related]
18. Spinal effects of selective NK-1 and NK-2 receptor antagonists on bladder motility in anesthetized rats.
Maggi CA; Lecci A; Garret C; Giuliani S
Regul Pept; 1993 Jul; 46(1-2):389-91. PubMed ID: 7692545
[No Abstract] [Full Text] [Related]
19. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
Maggi CA; Giuliani S; Ballati L; Lecci A; Manzini S; Patacchini R; Renzetti AR; Rovero P; Quartara L; Giachetti A
J Pharmacol Exp Ther; 1991 Jun; 257(3):1172-8. PubMed ID: 1710662
[TBL] [Abstract][Full Text] [Related]
20. Investigation of neurokinin-2 and -3 receptors in the human and pig bladder.
Templeman L; Sellers DJ; Chapple CR; Rosario DJ; Hay DP; Chess-Williams R
BJU Int; 2003 Nov; 92(7):787-92. PubMed ID: 14616468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
